← SynDRA

RABUSERTIB

SynDRA canonical compound SYN0037764 — structure-anchored drug synonym record

All known targets

• CHEK1

Mechanisms of action (all sources)

• CHEK1 INHIBITOR
• Serine/threonine-protein kinase Chk1 inhibitor
• CHK inhibitor
• CHEK1 MODULATOR

Cross-references

• PubChem CID: 11955855
• ChEMBL: CHEMBL3039517
• DrugBank: DB11662
• ChEBI: 124917
• KEGG: D10397
• TTD: D00NZL
• LINCS BRD: BRD-K14109347

Synonyms

• LY-2603618
• IC-83
• LY2603618
• UNII-3S9L1NU6U7
• 3S9L1NU6U7
• ly2603618 IC-83
• (S)-1-(5-bromo-4-methyl-2-(morpholin-2-ylmethoxy)phenyl)-3-(5-methylpyrazin-2-yl)urea
• n-(5-bromo-4-methyl-2-((2s)-2-morpholinylmethoxy)phenyl)-n'-(5-methyl-2-pyrazinyl)urea
• LY2603618 (IC-83)
• Rabusertib [USAN:INN]
• 3-(5-Bromo-4-methyl-2-[(2s)-morpholin-2-ylmethoxy]phenyl)-1-(5-methylpyrazin-2-yl)urea
• N-[5-Bromo-4-methyl-2-[(2S)-2-morpholinylmethoxy)phenyl]-N'-(5-methyl-2-pyrazinyl)urea
• Rabusertib (LY2603618)
• LY2603618 - IC-83
• LY2603618(IC-83)
• Urea, N-(5-bromo-4-methyl-2-((2S)-2-morpholinylmethoxy)phenyl)-N'-(5-methyl-2- pyrazinyl)-
• (S)-1-(5-bromo-4-methyl-2-(morpholin-2-ylmethoxy)phenyl)-3-(5-methylpyrazin-2-yl)urea.
• Rabusertib [USAN]
• 1-[5-bromo-4-methyl-2-[[(2S)-morpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea
• RABUSERTIB [INN]
• Rabusertib (USAN/INN)
• RABUSERTIB [WHO-DD]
• MLS006011026
• SCHEMBL304747
• GTPL7960
• CHEMBL3039517
• DTXSID50238417
• EX-A426
• CHEBI:124917
• BCPP000178
• BDBM50524309
• NSC761188
• NSC800860
• s2626
• ZINC70466463
• AKOS027422721
• BCP9000873
• CCG-264970
• CS-0472